These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 65339)

  • 41. A study of early pregnancy factor activity in the sera of women with trophoblastic tumor.
    Fan X; Yan L; Jia S; Ma A; Qiao C
    Am J Reprod Immunol; 1999 Mar; 41(3):204-8. PubMed ID: 10326623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measurement of human chorionic gonadotropin.
    Goldstein DP; Berkowitz RS; Kosasa TS
    Major Probl Obstet Gynecol; 1982; 14():64-97. PubMed ID: 6273663
    [No Abstract]   [Full Text] [Related]  

  • 43. ABO blood group in patients with malignant trophoblastic disease.
    Sasaki K; Hata H; Nakano R
    Gynecol Obstet Invest; 1985; 20(1):23-6. PubMed ID: 2995210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The diagnostic value of circulating trophoblast-specific beta 1-glycoprotein (TSG) in cancer patients.
    Tatarinov YS
    Br J Cancer; 1980 May; 41(5):821-4. PubMed ID: 6252917
    [No Abstract]   [Full Text] [Related]  

  • 45. The concentration of HCG in the plasma and spinal fluid of patients with trophoblastic tumours in the central nervous system.
    Rushworth AG; Orr AH; Bagshawe KD
    Br J Cancer; 1968 Jun; 22(2):253-7. PubMed ID: 4298235
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of variations in globulin concentrations on serum radioimmunoassay results, as exemplified by choriogonadotropin.
    Jawad MJ; Wilson EA
    Clin Chem; 1981 Dec; 27(12):1993-6. PubMed ID: 6171362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of trophoblastic tumour activity by pregnancy-specific beta-1-glycoprotein.
    Seppälä M; Rutanen EM; Heikinheimo M; Jalanko H; Engvall E
    Int J Cancer; 1978 Mar; 21(3):265-7. PubMed ID: 631928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
    Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
    Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum testosterone and dihydrotestosterone in patients with trophoblastic disease.
    Dawood MY; Saxena BB
    Obstet Gynecol; 1976 Jun; 47(6):684-8. PubMed ID: 180465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management and outcome of healthy women with a persistently elevated beta-hCG.
    Palmieri C; Dhillon T; Fisher RA; Young AM; Short D; Mitchell H; Aghajanian C; Savage PM; Newlands ES; Hancock BW; Seckl MJ
    Gynecol Oncol; 2007 Jul; 106(1):35-43. PubMed ID: 17482245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative serum levels of pregnancy associated alpha2-globulin in patients with benign and malignant tumours.
    Than GN; Csaba IF; Szabó DG; Karg NJ; Novák PF
    Arch Gynakol; 1975; 218(2):125-30. PubMed ID: 50829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The clinical significance of the immunoenzyme determination of trophoblastic beta 1-glycoprotein].
    Bogdanovich RN; Berestovaia TA
    Lab Delo; 1990; (9):43-5. PubMed ID: 1702860
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of an immunoradiometric assay and a radioimmunoassay for the detection of free beta-human chorionic gonadotropin.
    Shapiro AI; Wu TF; Ballon SC; Lamb EJ
    Obstet Gynecol; 1985 Apr; 65(4):545-9. PubMed ID: 2580254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Utility of assay of alpha subunit of human chorionic gonadotropin in management of gestational, trophoblastic malignancies.
    Quigley MM; Tyrey L; Hammond CB
    Am J Obstet Gynecol; 1980 Nov; 138(5):545-9. PubMed ID: 6158863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The kinetics of chorionic gonadotropin and its subunits in normal pregnancy and gestational trophoblastic neoplasms].
    Kunhardt J; Calderón J; Rodríguez S; Fletcher P; Ayala A; Reyes V
    Ginecol Obstet Mex; 1987 Jul; 55():188-91. PubMed ID: 2484840
    [No Abstract]   [Full Text] [Related]  

  • 58. Criteria of complete remission from trophoblastic neoplasia with the use of human chorionic gonadotropin (HCG) excretion pattern as a parameter.
    Tomoda Y; Asai Y; Arii Y; Kaseki S; Nishi H; Miwa T; Saiki N; Ishizuka N
    Cancer; 1977 Sep; 40(3):1016-25. PubMed ID: 198083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative analysis of a novel pregnancy-associated protein in trophoblastic diseases, normal pregnancy and healthy female subjects.
    Nakai M; Atsumi M; Odagiri J; Arai M
    Arch Gynecol Obstet; 1988; 243(2):107-10. PubMed ID: 2840861
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The c-erbB-related oncoproteins in normal placenta and in gestational trophoblastic diseases (in vitro study)].
    Fülöp V; Végh G; Doszpod J
    Orv Hetil; 2001 Jun; 142(22):1147-54. PubMed ID: 11424588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.